IP Library Granted Patent US 6,987,106
Granted Patent B1
US 6,987,106 · App. 09/937,045 · Granted Jan 17, 2006

1,4-diazabicyclo[3.2.2]nonane-4-carboxylates and carboxamide derivates, production and use thereof in therapeutics

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,987,106
App. No.
09/937,045
Granted
Jan 17, 2006
Kind
B1
Abstract

Compounds of general formula in which X represents an oxygen atom or a group of formula NZ in which Z represents a hydrogen atom or an alkyl group, n represents a number 0, 1 or 2, and R 1 , R 2 , R 3 , R 4 and R 5 each represent a hydrogen or halogen atom or a trifluoromethyl, trifluoromethoxy, cyano, hydroxyl, alkyl, alkoxy, phenoxy or phenyl group optionally substituted with a halogen atom or a trifluoromethyl, cyano, hydroxyl, alkyl or alkoxy group, or alternatively R 2 and R 3 together form a group of formula —OCH 2 O— or —CH 2 CH 2 CH 2 CH 2 —. Application in therapy.

Claims (9)

1. A compound corresponding to the formula (I)

in which

X represents an oxygen atom or a group of formula NZ in which Z represents a hydrogen atom or a (C 1 –C 6 )alkyl group,

n represents a number 0, 1 or 2, and R 1 , R 2 , R 3 , R 4 and R 5 each represent, independently of each other, a hydrogen or halogen atom or a trifluoromethyl, trifluoromethoxy, cyano, hydroxyl, (C 1 –C 6 )alkyl, (C 1 –C 6 )alkoxy, phenoxy or phenyl group optionally substituted with a halogen atom or a trifluoromethyl, cyano, hydroxyl, (C 1 –C 6 )alkyl or (C 1 –C 6 )alkoxy group, or alternatively R 2 and R 3 together form a group of formula OCH 2 O— or —CH 2 CH 2 CH 2 CH 2 —, in the form of a base or of an addition salt with an acid.

2. A pharmaceutical composition comprising a compound according to claim 1 , combined with an excipient.

3. A method for the treatment of Alzheimer's disease or schizophrenia which comprises administering to a patient in need of such treatment an effective amount of a compound according to claim 1 .

4. 4-Bromophenyl-1,4-diazabicyclo[3.2.2]nonane-4-carboxylate according to claim 1 .

5. A pharmaceutical composition comprising a compound according to claim 4 , combined with an excipient.

6. A method for the treatment of Alzheimer's disease or schizophrenia which comprises administering to a patient in need of such treatment an effective amount of a compound according to claim 4 .

Assignments (3)
CHANGE OF NAME Recorded Jun 20, 2012
From: SANOFI-AVENTIS
To: SANOFI
Reel/Frame 028413/0927 →
CHANGE OF NAME Recorded Jul 22, 2005
From: SANOFI-SYNTHELABO
To: SANOFI-AVENTIS
Reel/Frame 016345/0189 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2001
From: GALLET, THIERRY; JEGHAM, SAMIR; LARDENOIS, PATRICK; LOCHEAD, ALISTAIR; NEDELEC, ALAIN
To: SANOFI-SYNTHELABO
Reel/Frame 012289/0680 →